Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Using mutation data to guide sequencing
She envisions serial BTK mutation testing to guide when to use degraders or noncovalent inhibitors, but it's not routine yet.
Play episode from 50:32
Transcript
